Cytoreduction Surgical Procedures
"Cytoreduction Surgical Procedures" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Operative procedures carried out to reduce a mass of tissue, for example, to reduce the total amount of tissue composing a tumor.
|Cytoreduction Surgical Procedures
- Cytoreduction Surgical Procedures
- Cytoreduction Surgical Procedure
- Procedure, Cytoreduction Surgical
- Surgical Procedure, Cytoreduction
- Debulking Surgical Procedures
- Debulking Surgical Procedure
- Procedure, Debulking Surgical
- Surgical Procedure, Debulking
- Cytoreductive Surgery
- Cytoreductive Surgeries
- Surgery, Cytoreductive
- Cytoreductive Surgical Procedures
- Cytoreductive Surgical Procedure
- Procedure, Cytoreductive Surgical
- Surgical Procedure, Cytoreductive
- Surgical Procedures, Cytoreductive
Below are MeSH descriptors whose meaning is more general than "Cytoreduction Surgical Procedures".
Below are MeSH descriptors whose meaning is more specific than "Cytoreduction Surgical Procedures".
This graph shows the total number of publications written about "Cytoreduction Surgical Procedures" by people in this website by year, and whether "Cytoreduction Surgical Procedures" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Cytoreduction Surgical Procedures" by people in Profiles.
Association between Serum Biomarkers with Postoperative Complications and Delay of Adjuvant Chemotherapy Initiation in Ovarian Cancer Patients Undergoing Primary Cytoreductive Surgery: A Pilot Study. Nutr Cancer. 2023; 75(2):662-669.
Is there a role for secondary debulking in ovarian cancer? A review of the current literature. Curr Opin Obstet Gynecol. 2023 02 01; 35(1):1-5.
Women survive longer than men undergoing cytoreductive surgery and HIPEC for appendiceal cancer. PLoS One. 2021; 16(4):e0250726.
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39). J Clin Oncol. 2021 06 10; 39(17):1842-1855.
Should we or should we not? Secondary debulking in ovarian cancer. Lancet Oncol. 2021 04; 22(4):412-413.
Optimizing patient selection for cytoreductive nephrectomy based on outcomes in the contemporary era of systemic therapy. Cancer. 2020 09 01; 126(17):3950-3960.
Neuroendocrine Tumors of the Pancreatobiliary and Gastrointestinal Tracts. Surg Clin North Am. 2020 Jun; 100(3):635-648.
In Reply to the Letter to the Editor Regarding "Resection of Pediatric Trigeminal Schwannoma Using Minimally Invasive Approach: Case Report, Literature Review and Operative Video". World Neurosurg. 2020 02; 134:683.
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer. N Engl J Med. 2019 11 14; 381(20):1929-1939.
In Reply to the Letter to the Editor Regarding "Resection of Pediatric Trigeminal Schwannoma Using Minimally Invasive Approach: Case Report, Literature Review, and Video Submission". World Neurosurg. 2019 11; 131:293.